Latest News and Press Releases

Pipeline advancements: The Marketing Authorization Application (MAA) for Day One Biopharmaceuticals and Ipsen’s tovorafenib was accepted for review by the European Marketing Authority (EMA) and Takeda...

LEWISVILLE, Ark., May 06, 2025 (GLOBE NEWSWIRE) -- Smackover Lithium, a Joint Venture (“JV”) between Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV:SLI) (NYSE:A:SLI) and Equinor,...

HALIFAX, Nova Scotia, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Morien Resources Corp. ("Morien" or the "Company") (TSX-V:MOX) applauds the Nova Scotia Government’s strong support for the province’s natural...

MONTRÉAL, 23 déc. 2024 (GLOBE NEWSWIRE) -- Redevances Aurifères Osisko Ltée (« Osisko » ou la « Société ») (TSX et NYSE : OR) a le plaisir d’annoncer qu'elle a complété une modification à...

MONTRÉAL, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Osisko Gold Royalties Ltd (“Osisko” or the “Company”) (OR: TSX & NYSE) is pleased to announce that it has completed an amendment to its silver...

XOMA Royalty January 2025 Dividend Record and Payment Dates

HALIFAX, Nova Scotia, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Morien Resources Corp. ("Morien" or the "Company") (TSX-V:MOX) is pleased to provide the following corporate and project update to its...

XOMA Royalty acquires 50% economic interest in portfolio of 60-plus early-stage assets with $15M payment to Twist Bioscience

MIPLYFFA(TM) becomes 6th commercial asset in XOMA Royalty's portfolio

July 2024 Dividends